Skip to main navigation Skip to search Skip to main content

An Open-label Pilot Study with an Extension Phase to Evaluate the Pharmacokinetics, and to Generate Preliminary Safety, Tolerability, and Efficacy of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Pediatric

University at Buffalo

Project: Research

Project Details

StatusFinished
Effective start/end date02/27/12 → 07/31/15

Funding

  • Eisai Incorporated: $79,579.29